Loading clinical trials...

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT00536471

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Study F1J-US-HMFS comprises two identical multicenter, 9-month, randomized, placebo-controlled, double-blind, trials (HMFSa and HMFSb). The purpose of this study is to compare the efficacy and safety ...

Lead sponsor: Eli Lilly and Company•43 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

NCT07592689 · Major Depressive Disorder

RECRUITINGPhase 2

Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression

NCT07539805 · Major Depressive Disorder (MDD), Probiotic Intervention

RECRUITINGPhase 2

Sertraline Combined With Multi-Strain Probiotics for Adolescent Depression

NCT07645157 · Major Depressive Disorder (MDD), Probiotic Intervention

RECRUITINGNA

Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients

NCT07642882 · Fibromyalgia, Depression - Major Depressive Disorder, and more

RECRUITINGPhase 2

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

NCT07621237 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 20, 2009Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment776

Start dateSep 2007

Last updatedNov 20, 2009

Condition

Major Depressive Disorder

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Beverly Hills, California

Escondido, California

National City, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 20, 2009Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression

Sertraline Combined With Multi-Strain Probiotics for Adolescent Depression

Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Trial snapshot

Condition

Locations shown

For caregivers